Illicit drug trade is fueling regional conflict and instability in Myanmar.
Steady: 1 in the last 7 days
Updated oct 24
The latest in this situation
How it started
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Illicit drug trade is fueling regional conflict and instability in Myanmar.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.- Major drug busts occur in key cities of Myanmar, with Shan state identified as a major drug production area.Sub-event
Drug production in Shan fuels conflict and supplies Southeast Asia.1 source
Drug trade is cited as a cause of regional conflict and instability in Myanmar.1 source
Keep exploring
The entities involved
-
Myanmar
country in Southeast Asia
- China's geopolitical tilt toward the Myanmar junta is highlighted alongside scheduled Trump-Xi talks and US concerns over transnational crime.
- Rohingya refugees are attempting dangerous crossings from Myanmar into host countries, including Malaysia and Bangladesh, while the UN investigates the root causes.
-
Mandalay
cultural city in Mandalay Region, Myanmar
Nothing else this week.
Related events
- Anti-narcotics measures intensify pressure on drug trafficking routes connecting Afghanistan, the Golden Triangle, and Myanmar.
- Myanmar overtakes Afghanistan as the top illicit opium source, prompting warnings from NCB regarding drug trade risks to India.
- Drug trade routes are facilitating cross-border trafficking of methamphetamine across Northern Thailand, Laos, and Myanmar.
- Drug smuggling is occurring across the border between Myanmar and Thailand.
- The shared border between Myanmar and Mizoram (a state in India) is being utilized to facilitate drug transit and smuggling.
Coverage
Newest first; wire copies grouped- tennesseedaily.com
- tribuneindia.com
- bangladeshsun.com
- japanherald.com
- brazilsun.com
- parisguardian.com